Day One

8:00 am - 8:30 am Registration and Breakfast

8:30 am - 8:45 am Welcome and Opening Remarks from Chairperson

8:45 am - 9:30 am Moving to a Patient-Centric Mindset in Cell and Gene Therapy – What Can Supply Chain Leaders Do to Impact Outcomes?

David Kim - Director of Global Logistics, Kite Pharma, a Gilead Company

David Kim

Director of Global Logistics
Kite Pharma, a Gilead Company

9:30 am - 10:15 am Developing an Ideal CAR-T Patient Experience through Human Centered Design

Allison Matthews - Service Designer, Innovation and Design, Mayo Clinic
As Mayo Clinic developed a CAR-T service line, the patient experience was specifically and carefully designed to allow teams to deliver not only lifesaving treatments but ensure that the care provided supports all of the patients’ needs throughout. The session will include the principles and insights that guided the development of a unique patient experience, tools and processes developed, and reflections from patients.

Allison Matthews

Service Designer, Innovation and Design
Mayo Clinic

10:15 am - 10:45 am Morning Coffee and Networking Break


10:45 am - 11:25 am Supply Chain Digitization: Building End-to-End Visibility in Operating Procedures and Discussing Possible Standardization for In-patient Processes

11:25 am - 12:20 pm Panel Discussion:Industry Working Group

Sanjay Srivastava PhD - Managing Director for Cell & Gene, Life Sciences, Accenture
Despite recent progress in Cell and Gene Therapy, huge supply chain and operational challenges are hindering commercialization- including the lack of standardization of operational processes at the hospital collection points. This session will provide the most recent findings and collaborative efforts of 12 pharma manufacturers to overcome this challenge and establish standardized processes in the collection and dissemination of products. Discover in this unprecedented session how unique and effective industry collaboration and improve order fulfilment and operational processes for cell therapy treatments.

Sanjay Srivastava PhD

Managing Director for Cell & Gene, Life Sciences

12:20 pm - 1:00 pm Hospitals and Clinics Panel Discussion: Re-Designing and Standardizing the Processes at Hospital Collection Points

Albert Ribickas - Manager BMT/QC laboratories Cell Therapy Facility, Moffitt Cancer Center

Albert Ribickas

Manager BMT/QC laboratories Cell Therapy Facility
Moffitt Cancer Center

1:00 pm - 2:00 pm Networking Lunch

Delegates will get the opportunity to select 3 tables of their choice, each led by a roundtable host for a 30 minutes discussion. All 6 roundtables will kick start simultaneously, with delegates rotating after each 30 minute session. You have the unique opportunity to discuss how to apply federal and states updates to your products presentation and to ask the most pressing questions, thereby guaranteeing a perfectly tailored experience.

Topical Interactive Roundtable Discussions

Roundtable 1

2:00 pm - 2:30 pm Building scalable cell processing systems

Roundtable 2

2:00 pm - 2:30 pm Innovative Solutions for Cell Labelling to Secure Tracking

Roundtable 3

2:00 pm - 2:30 pm Designing Optimal Collection Cell Therapy Facilities

Roundtable 4

2:30 pm - 3:00 pm Outsourcing: What to Keep in Mind

Roundtable 5

2:30 pm - 3:00 pm Overcoming CAR-T cell Manufacturing Challenges

Roundtable 6

2:30 pm - 3:00 pm Cryogenic Preservation: Challenges for CAR-T logistics

3:00 pm - 3:30 pm Afternoon Coffee and Networking Break


3:00 pm - 3:30 pm Automated Manufacture: Importance of Creating Fully Automated Single-use Closed Systems for Packaging and Handling of Materials

3:30 pm - 4:00 pm Ready or Not: How to Overcome Logistical and Track and Trace Challenges in the Commercial Phase

4:00 pm - 4:30 pm From Labelling to Secure Tracking: Understanding the Need for a Standardized Labelling system to Ensure the Safety and Traceability

5:00 pm - 5:15 pm Closing Remarks by Chairperson and End of Day One